Company Filing History:
Years Active: 2017-2023
Title: The Innovative Contributions of Sarita Mittal
Introduction
Sarita Mittal is a prominent inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the development of stable formulations for therapeutic antibodies. With a total of 2 patents, her work has the potential to impact cancer treatment and biopharmaceutical production.
Latest Patents
Sarita Mittal's latest patents include two notable inventions. The first patent focuses on stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use thereof. This invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof. The formulations comprise between 5-200 mg/mL of anti-PD-1 antibody, or its fragments. The invention also provides methods for treating various cancers using these stable formulations, which can be administered intravenously or subcutaneously.
The second patent involves liquid formulations for TNFR:Fc fusion proteins. This invention provides stable liquid formulations for a recombinant biopharmaceutical protein that includes a soluble form of the human p75 TNF receptor fused to an Fc domain of a human immunoglobulin protein (TNFR:Fc). These formulations are crucial for ensuring the consistent and reproducible quality of biopharmaceutical products, which are often produced using recombinant DNA technology in mammalian cell expression systems.
Career Highlights
Sarita Mittal is currently employed at Merck Sharp & Dohme Corporation, where she continues to advance her research in biopharmaceuticals. Her work is characterized by a commitment to innovation and quality in the development of therapeutic formulations.
Collaborations
Throughout her career, Sarita has collaborated with notable colleagues, including Ramesh Kashi and Ashwin Basarkar. These collaborations have contributed to her success and the advancement of her research projects.
Conclusion
Sarita Mittal's contributions to the field of biopharmaceuticals through her innovative patents demonstrate her expertise and commitment to improving cancer treatment options. Her work at Merck Sharp & Dohme Corporation continues to pave the way for advancements in therapeutic formulations.